12:00 AM
 | 
Jun 12, 2000
 |  BC Week In Review  |  Company News  |  Deals

Adenosine, National Institute of Diabetes and Digestive and Kidney Diseases, University of Virginia deal

Adenosine Therapeutics exclusively licensed 50 adenosine A2B receptor antagonists from the university and the...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >